WO1998015505A1 - Production of porous articles - Google Patents
Production of porous articles Download PDFInfo
- Publication number
- WO1998015505A1 WO1998015505A1 PCT/GB1997/002705 GB9702705W WO9815505A1 WO 1998015505 A1 WO1998015505 A1 WO 1998015505A1 GB 9702705 W GB9702705 W GB 9702705W WO 9815505 A1 WO9815505 A1 WO 9815505A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymerisation
- dispersion
- foam
- article
- particles
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- 239000002245 particle Substances 0.000 claims abstract description 28
- 239000006185 dispersion Substances 0.000 claims abstract description 25
- 239000000919 ceramic Substances 0.000 claims abstract description 16
- 239000000178 monomer Substances 0.000 claims abstract description 9
- 239000003054 catalyst Substances 0.000 claims abstract description 8
- 239000003999 initiator Substances 0.000 claims abstract description 7
- 239000006260 foam Substances 0.000 claims description 32
- 238000000034 method Methods 0.000 claims description 30
- 239000000463 material Substances 0.000 claims description 21
- 239000011148 porous material Substances 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 19
- 239000007789 gas Substances 0.000 claims description 15
- 239000007787 solid Substances 0.000 claims description 11
- 238000001035 drying Methods 0.000 claims description 10
- 238000010304 firing Methods 0.000 claims description 10
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 9
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 9
- 239000011230 binding agent Substances 0.000 claims description 8
- 210000002449 bone cell Anatomy 0.000 claims description 8
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims description 6
- 238000013019 agitation Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 239000002270 dispersing agent Substances 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 229910052581 Si3N4 Inorganic materials 0.000 claims description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 2
- KZHJGOXRZJKJNY-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Si]=O.O=[Al]O[Al]=O.O=[Al]O[Al]=O.O=[Al]O[Al]=O KZHJGOXRZJKJNY-UHFFFAOYSA-N 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 229910052863 mullite Inorganic materials 0.000 claims description 2
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 claims description 2
- 229910010271 silicon carbide Inorganic materials 0.000 claims description 2
- HQVNEWCFYHHQES-UHFFFAOYSA-N silicon nitride Chemical compound N12[Si]34N5[Si]62N3[Si]51N64 HQVNEWCFYHHQES-UHFFFAOYSA-N 0.000 claims description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 15
- 210000000988 bone and bone Anatomy 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 239000002002 slurry Substances 0.000 description 7
- 239000004094 surface-active agent Substances 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 5
- 238000005187 foaming Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 4
- 239000000316 bone substitute Substances 0.000 description 3
- 238000004581 coalescence Methods 0.000 description 3
- 238000005245 sintering Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000014653 Carica parviflora Nutrition 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- WPKYZIPODULRBM-UHFFFAOYSA-N azane;prop-2-enoic acid Chemical compound N.OC(=O)C=C WPKYZIPODULRBM-UHFFFAOYSA-N 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 229910010293 ceramic material Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000001054 cortical effect Effects 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- -1 diaphragms Substances 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000001000 micrograph Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000518 rheometry Methods 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 1
- PLFJWWUZKJKIPZ-UHFFFAOYSA-N 2-[2-[2-(2,6,8-trimethylnonan-4-yloxy)ethoxy]ethoxy]ethanol Chemical compound CC(C)CC(C)CC(CC(C)C)OCCOCCOCCO PLFJWWUZKJKIPZ-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 239000004160 Ammonium persulphate Substances 0.000 description 1
- 241000242757 Anthozoa Species 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002386 air freshener Substances 0.000 description 1
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 1
- 235000019395 ammonium persulphate Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000005312 bioglass Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000567 combustion gas Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000002316 cosmetic surgery Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000000280 densification Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000001497 fibrovascular Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000007792 gaseous phase Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000012774 insulation material Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B38/00—Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof
- C04B38/0038—Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by superficial sintering or bonding of particulate matter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B38/00—Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof
- C04B38/06—Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by burning-out added substances by burning natural expanding materials or by sublimating or melting out added substances
- C04B38/0615—Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by burning-out added substances by burning natural expanding materials or by sublimating or melting out added substances the burned-out substance being a monolitic element having approximately the same dimensions as the final article, e.g. a porous polyurethane sheet or a prepreg obtained by bonding together resin particles
- C04B38/062—Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by burning-out added substances by burning natural expanding materials or by sublimating or melting out added substances the burned-out substance being a monolitic element having approximately the same dimensions as the final article, e.g. a porous polyurethane sheet or a prepreg obtained by bonding together resin particles the burned-out substance being formed in situ, e.g. by polymerisation of a prepolymer composition containing ceramic powder
- C04B38/0625—Porous mortars, concrete, artificial stone or ceramic ware; Preparation thereof by burning-out added substances by burning natural expanding materials or by sublimating or melting out added substances the burned-out substance being a monolitic element having approximately the same dimensions as the final article, e.g. a porous polyurethane sheet or a prepreg obtained by bonding together resin particles the burned-out substance being formed in situ, e.g. by polymerisation of a prepolymer composition containing ceramic powder involving a foaming step of the burnable material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00179—Ceramics or ceramic-like structures
- A61F2310/00293—Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
- C04B2111/00474—Uses not provided for elsewhere in C04B2111/00
- C04B2111/00836—Uses not provided for elsewhere in C04B2111/00 for medical or dental applications
Definitions
- the invention relates to the production of articles of controlled porosity.
- the monomeric material is selected to polymerise by cross linking, whereby the liquid carrier and ceramic particles are held within the polymerised structure.
- the method of this prior patent is arranged to produce a variety of useful articles such as catalyst supports, flame supports; gas filters; air fresheners; ceramic armour; diesel paniculate traps; insulation materials; artificial parts for the body; metal filters, reusable filters; liquid filters; storage and transportation for flammable and/or toxic materials, humidity sensors, chromatography; filter candles for filtration of hot combustion gases, diaphragms, membranes, refractory separators, phase dividers and electrolytes for high temperature fuel cells.
- useful articles such as catalyst supports, flame supports; gas filters; air fresheners; ceramic armour; diesel paniculate traps; insulation materials; artificial parts for the body; metal filters, reusable filters; liquid filters; storage and transportation for flammable and/or toxic materials, humidity sensors, chromatography; filter candles for filtration of hot combustion gases, diaphragms, membranes, refractory separators, phase dividers and electrolytes for high temperature fuel cells.
- the decomposition rate of the gas generating substance is controlled. This in turn provides a means of controlling the density of the end product. It is one object of the invention to provide a method of making a porous article having controlled levels of porosity, mterconnectivity, pore size, and mechanical properties suitable for use in various applications.
- the invention provides a method of making a porous article composed of bonded particles, the method comprising the steps of:
- the dispersion comprises particles having an average particle size less than about 5 micrometres and preferably 95% of the particles will be less than about 2 micrometres. If the particles are larger than this size than the particles tend to settle or sediment.
- the particles can be much larger, say 100 micrometres or more, in which case agents will be present to control undesired settling; polymerisation of monomers is a suitable means of preventing settling.
- the particles will be chosen according to the intended end use. As will be explained later, for the preferred use hydroxyapatite is present either alone or with other particles.
- the other particles can include both oxides and non-oxides such as alumina, mullite, silicon carbide, silicon nitride, zirconia, titanium oxide and the like.
- the content of the solids in the dispersion will tend to be about 10% by weight as a nrinimum and about 90% by weight as a maximum; a preferred range is from about 40% to about 80%) by weight.
- the liquid carrier is water but it may be organic, e.g. alcohol, glycol or the like; or a mixture.
- dispersing agents are commonly used throughout the ceramic industry and suitable agents in each case can be determined by the man skilled in the art.
- the colloidal stability may be controlled by the adjustment of the pH, in addition to or alternating to the dispersion
- surfactants which can be cationic, anionic or non-ionic
- surfactant type and concentration can have a direct influence not only on the level of porosity within the system but also the pore size and the mterconnectivity.
- concentration of surfactant can be used to influence the bubble size within a foam and the rate of coalescence, both of which can be used to influence the final pore size.
- a slurry which exhibits a low degree of pseudoplasticity coupled with a low bulk viscosity is susceptible to foam collapse and rapid bubble growth.
- a slurry which exhibits a high degree of pseudoplasticity is subject to long term stability and a less rapid bubble growth although at an acceptable level.
- the bulk viscosity of the system increases the controlling effect of the surfactant diminishes.
- Another factor which influences the growth of the foam structure is the period before the onset of polymerisation.
- This period can be controlled by the addition levels of the initiator and catalyst. By controlling these levels as well as the oxygen concentration within the foaming gas the length of time before polymerisation starts can be controlled between an instantaneous polymerisation and one which starts after a period, which can be up to 20 minutes or more.
- Our evaluations suggest that this period has a major influence on cell structure where the porous article is to be used as a bone substitute.
- the process of increasing the cell size within a foam can be encouraged by the application of a partial vacuum to a foam before the commencement of polymerisation until after the end of polymerisation. At the end of polymerisation the stable foam is brought back to atmospheric pressure. This additional step to the foaming process can be used to increase the rate at which the final desired large cell size can be achieved.
- additives may be present, e.g. viscosity control agents, reinforcing fibres or particles, retarders for polymerisation; and the like.
- the bubbles of gas may be introduced in any convenient way, although the preferred methods are listed in our previous patent.
- the gas used for foaming can be air, although an inert foaming gas such as nitrogen or argon is preferred.
- an inert foaming gas such as nitrogen or argon is preferred.
- a number of cells can be seen in the left hand photo in Figure 1. These cells are formed as a result of introducing a gaseous phase into the ceramic suspension. Where these cells touch there is a tendency for the cell to change shape to maximise the packing density and for the slurry to drain from the point of contact towards the strut.
- a strut can be seen in the top right hand photo in Figure 1. These struts are the building block for the foam structure. At the point of contact between each cell a thin film of liquid exists. During the later gelling and binder burnout steps this film is removed to leave what we call the cell "windows". These are the connecting holes which interlink adjacent cells and can be clearly seen in the left hand photo in Figure 1. The final structure is that which forms the cell walls and struts.
- the final articles formed consist essentially of the starting ceramic materials only, so avoiding the need for the removal of residual secondary e.g. inorganic binders.
- the article can thus consist of ingredients acceptable for medical use, e.g. as bone grafts for orthopaedic, surgical, dental and like uses both for humans and animals. There will always be a need to replace bone lost as a consequence of traumatic or non-traumatic events.
- Bone substitute materials are available and approved for clinical use. These materials have been successfully used in orthopaedics, dentistry and facial plastic surgery.
- the porous types which can provide a scaffold for in growth of connective tissue and bone. Studies have shown that pore sizes less than 10 micrometre prevent ingrowth of cells, pore sizes of 15 to
- 50 micrometre encourages fibro vascular ingrowth; pore sizes of 50-150 micrometre result in osteoid formation; and pore sizes greater than 150 micrometre facilitate the ingrowth of mineralized bone.
- Different approaches have been taken to try and mimic the hydroxyapatite frame work within both the cortical and cancellous bone.
- One material is based on the conversion of a coralline structure to hydroxyapatite material.
- Hydroxyapatite [Ca ⁇ 0 (PO 4 ), (OH) 2 ] is an ideal candidate starting material.
- This material belongs to a group of calcium phosphates which are being considered as bone substitute materials.
- the invention is applicable to hydroxyapatite and any other calcium phosphate (where the Ca/P atomic ratio may vary widely).
- it may be advantageous to create an interconnected structure in another ceramic material such as alumina or zirconia for mechanical property reasons and either use the material as produced, or coated with a more bioactive material such as hydroxyapatite. It is another feature of this invention that the materials known as
- the polymerisation preferably proceeds by crosslinking of reactive organic monomers.
- reactive organic monomers include acrylates, such as ammonium acrylate or hydroxyethyl methacrylate; or the like.
- the monomers are dissolved in water or other liquid carrier to give a premix solution.
- an initiator and either heat or a catalyst are used to induce free radical vinyl polymerisation.
- the dispersion includes a monosaccharide such as galactose, which can be condensed to form a dimer, trimer or polymer, to have the same effect.
- the foamed composition may be allowed or caused to acquire sufficient green strength to allow it to be moved from the parent container or mould.
- the composition may be subjected to drying to drive off the liquid. In the case of water, drying can be carried out below about 100°C in an oven or using high frequency drying equipment.
- the pore sizes in the formed article can be controlled remarkable uniform to yield a material with a pre-determined pore size and level of mterconnectivity.
- the true porosity may range from about 20%> to about 95%>.
- the article formed is relatively robust after polymerisation and strong enough to be machined after removal of the liquid carrier.
- the firing temperature and duration are selected according to the nature of the particles, e.g. alumina generally requires a higher sintering temperature than hydroxyapatite.
- the invention provides a method of making a porous article composed of bonded particles, the method comprising the steps of:
- This microporous structure can have advantages in certain applications e.g. it may be infilled with certain drugs such as antibiotics or growth factors, to act as a slow release agent at the site of an implant and it appears to encourage the easy attachment of in-growing bone cells compared to a dense microstructure.
- the formed article may be in a variety of shapes, e.g. in the form of granules, bars, cylinders or rods, blocks or the like.
- Hydroxyapatite powder, ammonium acrylate monomer, methylenebisacrylamide, water, the ammonium salt of polyacrylate and the ammonium salt of polymethacrylate were mixed together to form a slurry which was subjected to a high shear mixer in order to remove any agglomerates within the slurry. This was transferred to a glove box within which the oxygen concentration was approx. 0.1%).
- a surfactant TERGITOL TMN10 was introduced into the slurry and the whole was agitated in a mixer designed to introduce air so that a foam will be formed.
- the amount by which the ceramic solid is foamed is dependant on the final density required, the solids content of the slurry and the shrinkage which will occur at the later stages of drying and firing.
- the amount of surfactant added determines the extent of foaming, and this was selected to achieve the required final density.
- Example I The method of Example I was repeated except that the rate of addition of the initiator and the catalyst were selected so that the time before onset of polymerisation was 16 minutes instead of 1.5 minutes.
- a highly porous foam exhibiting a larger cell size as shown in Figure 7 resulted. It can be seen from the different Figures that the time before the onset of polymerisation has had a major influence on the cell structure.
- Figure 1 is a general foam
- Figure 2 is a foam produced in Example I taken after an idle time of 1.5 minutes;
- Figure 3 is the polymerised foam of Example I fired at 1250°C for 2 hours;
- Figure 4 is the polymerised foam of Example I fired at 1350°C for 2 hours;
- Figure 5 is the fired product shown in Figure 3 after being immersed in a bone cell culture for 36 hours
- Figure 6 is the fired product shown in Figure 4 after being immersed in a bone cell culture for 36 hours
- Figure 7 is the foam produced in Example II.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Ceramic Engineering (AREA)
- Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Structural Engineering (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Porous Artificial Stone Or Porous Ceramic Products (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10517285A JP2001501902A (en) | 1996-10-04 | 1997-10-01 | Manufacture of porous articles |
AU45639/97A AU4563997A (en) | 1996-10-04 | 1997-10-01 | Production of porous articles |
EP97943989A EP0958261A1 (en) | 1996-10-04 | 1997-10-01 | Production of porous articles |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9620752A GB2317887A (en) | 1996-10-04 | 1996-10-04 | Porous ceramic articles; bone cell growth and drug carriers |
GB9620752.7 | 1996-10-04 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09269999 A-371-Of-International | 1999-06-28 | ||
US10/820,627 Continuation US20040253279A1 (en) | 1996-10-04 | 2004-04-08 | Production of porous articles |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998015505A1 true WO1998015505A1 (en) | 1998-04-16 |
Family
ID=10800966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1997/002705 WO1998015505A1 (en) | 1996-10-04 | 1997-10-01 | Production of porous articles |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0958261A1 (en) |
JP (1) | JP2001501902A (en) |
AU (1) | AU4563997A (en) |
GB (3) | GB2317887A (en) |
WO (1) | WO1998015505A1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6340648B1 (en) | 1999-04-13 | 2002-01-22 | Toshiba Ceramics Co., Ltd. | Calcium phosphate porous sintered body and production thereof |
DE10113108A1 (en) * | 2001-03-15 | 2002-10-02 | Dot Gmbh | Calcium phosphate materials containing active ingredient |
JP2002543930A (en) * | 1999-05-12 | 2002-12-24 | デー アンド イー クライオー シーシー | Ceramic wound treatment device |
EP1155705A3 (en) * | 2000-05-19 | 2003-10-15 | Ochi, Takahiro, Ph. D. | Biomaterial |
JP2004506679A (en) * | 2000-08-21 | 2004-03-04 | ダイテック・コーポレーション・リミテッド | Use of porous carriers |
US6713420B2 (en) | 2000-10-13 | 2004-03-30 | Toshiba Ceramics Co., Ltd. | Porous ceramics body for in vivo or in vitro use |
US6821916B2 (en) | 2001-09-13 | 2004-11-23 | Akira Myoi | Ceramics for in vivo use |
DE10328892A1 (en) * | 2003-06-26 | 2005-05-12 | Curasan Ag | Bone building agent and manufacturing process |
US6923021B2 (en) | 2000-12-21 | 2005-08-02 | Corning Incorporated | Method and apparatus for fused silica production |
US7514024B2 (en) | 2000-12-07 | 2009-04-07 | Hoya Corporation | Method for producing a porous sintered body of calcium phosphate-based ceramic |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19718672C1 (en) * | 1997-05-02 | 1998-09-24 | Zschimmer & Schwarz Gmbh & Co | Use of a sugar |
GB9821663D0 (en) * | 1998-10-05 | 1998-11-25 | Abonetics Ltd | Foamed ceramics |
GB9825109D0 (en) * | 1998-11-16 | 1999-01-13 | Dytech Corp Ltd | Porous ceramic matrices |
EP1108698B8 (en) * | 1999-12-16 | 2006-10-04 | IsoTis N.V. | Porous ceramic body |
CA2328818A1 (en) | 1999-12-16 | 2001-06-16 | Isotis B.V. | Porous ceramic body |
GB0019003D0 (en) * | 2000-08-04 | 2000-09-20 | Lo Wei Jen | Porous synthetic bone graft and method of manufacture thereof |
GB0020734D0 (en) * | 2000-08-22 | 2000-10-11 | Dytech Corp Ltd | Bicontinuous composites |
US6949251B2 (en) | 2001-03-02 | 2005-09-27 | Stryker Corporation | Porous β-tricalcium phosphate granules for regeneration of bone tissue |
AU2003256227A1 (en) * | 2002-07-30 | 2004-02-16 | Nanyang Technological University | Spherical nano-composite powder and a method of preparing the same |
JP4215595B2 (en) * | 2003-08-21 | 2009-01-28 | 安正 赤川 | Implant fixing member and implant composite material |
WO2007086964A2 (en) | 2005-10-21 | 2007-08-02 | University Of South Florida | Method of producing interconnected volumetric porosity in materials |
CA2965384C (en) | 2007-08-09 | 2021-06-22 | The Board Of Regents Of The University Of Texas System | Bi-layered bone-like scaffolds |
US8044105B2 (en) | 2008-02-04 | 2011-10-25 | Dow Global Technologies Llc | Water-based ceramic foams showing improved gel strength |
WO2011143226A1 (en) | 2010-05-11 | 2011-11-17 | Howmedica Osteonics Corp. | Organophosphorous, multivalent metal compounds, & polymer adhesive interpenetrating network compositions & methods |
WO2012158527A2 (en) | 2011-05-13 | 2012-11-22 | Howmedica Osteonics | Organophosphorous & multivalent metal compound compositions & methods |
CN109512678B (en) * | 2018-11-28 | 2022-04-08 | 福建工程学院 | Preparation method of denture film |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1580935A (en) * | 1967-05-18 | 1969-09-12 | ||
US4218255A (en) * | 1976-08-30 | 1980-08-19 | University Of Dayton | Porous ceramic carriers for controlled release of proteins, polypeptide hormones, and other substances within human and/or other mamillian species and method |
DE3108387A1 (en) * | 1980-03-05 | 1982-01-21 | The Toyo Rubber Industry Co., Ltd., Osaka | Process for producing porous ceramic moulded articles |
EP0058867A1 (en) * | 1981-02-20 | 1982-09-01 | mundipharma GmbH | Method of producing a tricalcium phosphate bone ceramic for application as a bone implant, especially to fill cavities or for setting bone fractures in place after fracture, and tricalcium phosphate ceramic shaped articles produced according to this method |
GB2142919A (en) * | 1983-07-09 | 1985-01-30 | Sumitomo Cement Co | Porous ceramic material and processes for preparing same |
US5011495A (en) * | 1990-02-16 | 1991-04-30 | The United States Of America As Represented By The Secretary Of The Army | Unique bone regeneration tricalcium phosphate |
WO1993004013A1 (en) * | 1991-08-12 | 1993-03-04 | Dytech Corporation Limited | Porous articles |
DE4313715A1 (en) * | 1993-04-27 | 1994-11-03 | Roehm Gmbh | Highly filled, foamed polymer material |
WO1995030631A1 (en) * | 1994-05-10 | 1995-11-16 | Dytech Corporation Limited | Production of ceramic articles |
GB2289466A (en) * | 1994-05-10 | 1995-11-22 | Dytech Corp Ltd | Porous ceramic articles |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56166843A (en) * | 1980-05-28 | 1981-12-22 | Mitsubishi Mining & Cement Co | Filler for bone broken section and void section |
JPS6021763A (en) * | 1983-07-15 | 1985-02-04 | ティーディーケイ株式会社 | Artificial bone material |
US4629464A (en) * | 1984-09-25 | 1986-12-16 | Tdk Corporation | Porous hydroxyapatite material for artificial bone substitute |
-
1996
- 1996-10-04 GB GB9620752A patent/GB2317887A/en not_active Withdrawn
- 1996-10-04 GB GB0100084A patent/GB2354518B/en not_active Expired - Lifetime
- 1996-10-04 GB GB0100085A patent/GB2354519B/en not_active Expired - Lifetime
-
1997
- 1997-10-01 EP EP97943989A patent/EP0958261A1/en not_active Withdrawn
- 1997-10-01 AU AU45639/97A patent/AU4563997A/en not_active Abandoned
- 1997-10-01 WO PCT/GB1997/002705 patent/WO1998015505A1/en not_active Application Discontinuation
- 1997-10-01 JP JP10517285A patent/JP2001501902A/en not_active Ceased
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1580935A (en) * | 1967-05-18 | 1969-09-12 | ||
US4218255A (en) * | 1976-08-30 | 1980-08-19 | University Of Dayton | Porous ceramic carriers for controlled release of proteins, polypeptide hormones, and other substances within human and/or other mamillian species and method |
DE3108387A1 (en) * | 1980-03-05 | 1982-01-21 | The Toyo Rubber Industry Co., Ltd., Osaka | Process for producing porous ceramic moulded articles |
EP0058867A1 (en) * | 1981-02-20 | 1982-09-01 | mundipharma GmbH | Method of producing a tricalcium phosphate bone ceramic for application as a bone implant, especially to fill cavities or for setting bone fractures in place after fracture, and tricalcium phosphate ceramic shaped articles produced according to this method |
GB2142919A (en) * | 1983-07-09 | 1985-01-30 | Sumitomo Cement Co | Porous ceramic material and processes for preparing same |
US5011495A (en) * | 1990-02-16 | 1991-04-30 | The United States Of America As Represented By The Secretary Of The Army | Unique bone regeneration tricalcium phosphate |
WO1993004013A1 (en) * | 1991-08-12 | 1993-03-04 | Dytech Corporation Limited | Porous articles |
DE4313715A1 (en) * | 1993-04-27 | 1994-11-03 | Roehm Gmbh | Highly filled, foamed polymer material |
WO1995030631A1 (en) * | 1994-05-10 | 1995-11-16 | Dytech Corporation Limited | Production of ceramic articles |
GB2289466A (en) * | 1994-05-10 | 1995-11-22 | Dytech Corp Ltd | Porous ceramic articles |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Section Ch Week 9631, Derwent World Patents Index; Class A18, AN 96-308081, XP002035476, ANONYMOUS: "Re-oxygenation during the polymerisation of vinyl monomer MEHQ - by purging with inert gas or reducing solubility of oxygen under partial vacuum, allowing time for adequate mixing" * |
RESEARCH DISCLOSURE, vol. 386, no. 003, 10 June 1996 (1996-06-10), EMSWORTH, GB * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6340648B1 (en) | 1999-04-13 | 2002-01-22 | Toshiba Ceramics Co., Ltd. | Calcium phosphate porous sintered body and production thereof |
JP2002543930A (en) * | 1999-05-12 | 2002-12-24 | デー アンド イー クライオー シーシー | Ceramic wound treatment device |
EP1155705A3 (en) * | 2000-05-19 | 2003-10-15 | Ochi, Takahiro, Ph. D. | Biomaterial |
JP2004506679A (en) * | 2000-08-21 | 2004-03-04 | ダイテック・コーポレーション・リミテッド | Use of porous carriers |
US6713420B2 (en) | 2000-10-13 | 2004-03-30 | Toshiba Ceramics Co., Ltd. | Porous ceramics body for in vivo or in vitro use |
US7514024B2 (en) | 2000-12-07 | 2009-04-07 | Hoya Corporation | Method for producing a porous sintered body of calcium phosphate-based ceramic |
US6923021B2 (en) | 2000-12-21 | 2005-08-02 | Corning Incorporated | Method and apparatus for fused silica production |
DE10113108A1 (en) * | 2001-03-15 | 2002-10-02 | Dot Gmbh | Calcium phosphate materials containing active ingredient |
DE10113108B4 (en) * | 2001-03-15 | 2007-07-26 | Dot Gmbh | Active substance-containing calcium phosphate materials |
US6821916B2 (en) | 2001-09-13 | 2004-11-23 | Akira Myoi | Ceramics for in vivo use |
DE10328892A1 (en) * | 2003-06-26 | 2005-05-12 | Curasan Ag | Bone building agent and manufacturing process |
US8778374B2 (en) | 2003-06-26 | 2014-07-15 | Curasan Ag | Bone formation agent and method of production |
Also Published As
Publication number | Publication date |
---|---|
EP0958261A1 (en) | 1999-11-24 |
GB0100084D0 (en) | 2001-02-14 |
JP2001501902A (en) | 2001-02-13 |
GB2354519B (en) | 2001-06-13 |
GB2354518B (en) | 2001-06-13 |
GB2354519A (en) | 2001-03-28 |
GB2354518A (en) | 2001-03-28 |
GB0100085D0 (en) | 2001-02-14 |
GB9620752D0 (en) | 1996-11-20 |
AU4563997A (en) | 1998-05-05 |
GB2317887A (en) | 1998-04-08 |
GB2354519A8 (en) | 2001-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1998015505A1 (en) | Production of porous articles | |
US6479418B2 (en) | Porous ceramic body | |
Sopyan et al. | Porous hydroxyapatite for artificial bone applications | |
JP3362267B2 (en) | Bioimplant material and method for producing the same | |
EP1117626B1 (en) | Foamed ceramics | |
Ebaretonbofa et al. | High porosity hydroxyapatite foam scaffolds for bone substitute | |
EP0598783B1 (en) | Porous articles | |
US6977095B1 (en) | Process for producing rigid reticulated articles | |
JP2004532685A (en) | Foamed sol-gel and method for producing the same | |
EP1231951B1 (en) | Process for producing rigid reticulated articles | |
US20040253279A1 (en) | Production of porous articles | |
Swain | Processing of porous hydroxyapatite scaffold | |
CN1762897A (en) | Preparation process of degradable foam-like strontium-doped calcium phosphate ceramic bone scaffold | |
CA2319969A1 (en) | Composites | |
US20040129650A1 (en) | Method for the production of a biocompatible polymer-ceramic composite material with a predetermined porosity | |
EP1108698B1 (en) | Porous ceramic body | |
ENDOPROSTHESIS | OM Beketov National University of Urban Economy in Kharkiv | |
Aizawa et al. | Development and biological evaluation of apatite fibre scaffolds with large pore size and high porosity for bone regeneration | |
Yasuda et al. | Preparation of porous hydroxyapatite/α-tricalcium phosphate composites by a colloidal process | |
Aizawa et al. | Fabrication of the Hybrid Materials by the Introduction of Poly (Methylmethacrylate) into the Porous Hydroxyapatite Ceramics | |
Min et al. | Effect of reaction conditions on pore configuration and mechanical property for porous hydroxyapatite prepared by polymer sponge method | |
Lofton et al. | Processing of bioactive ceramics with defined porosity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997943989 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1998 517285 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09269999 Country of ref document: US |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1997943989 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997943989 Country of ref document: EP |